P75 Stock Overview
Provides products and solutions for use of injectable drugs in Sweden. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Perpetua Medical AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 0.40 |
52 Week High | SEK 0.43 |
52 Week Low | SEK 0.043 |
Beta | 2.04 |
11 Month Change | 13.96% |
3 Month Change | 47.66% |
1 Year Change | 601.40% |
33 Year Change | -98.09% |
5 Year Change | n/a |
Change since IPO | -96.96% |
Recent News & Updates
Recent updates
Shareholder Returns
P75 | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | 4.8% | 2.4% | 0.8% |
1Y | 601.4% | -5.0% | 9.1% |
Return vs Industry: P75 exceeded the German Medical Equipment industry which returned -6.8% over the past year.
Return vs Market: P75 exceeded the German Market which returned 8.5% over the past year.
Price Volatility
P75 volatility | |
---|---|
P75 Average Weekly Movement | 26.7% |
Medical Equipment Industry Average Movement | 5.5% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.8% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: P75's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: P75's weekly volatility has decreased from 79% to 27% over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2007 | 4 | Anders Hedlund | perpetuamedical.se |
Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. The company offers DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of drug preparations. The company formerly known as Pharmacolog i Uppsala AB (publ) and changed its name to Perpetua Medical AB (publ) in April 2024.
Perpetua Medical AB (publ) Fundamentals Summary
P75 fundamental statistics | |
---|---|
Market cap | €1.96m |
Earnings (TTM) | -€448.87k |
Revenue (TTM) | €1.05m |
1.9x
P/S Ratio-4.4x
P/E RatioIs P75 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
P75 income statement (TTM) | |
---|---|
Revenue | SEK 12.08m |
Cost of Revenue | SEK 2.78m |
Gross Profit | SEK 9.30m |
Other Expenses | SEK 14.48m |
Earnings | -SEK 5.18m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 14, 2025
Earnings per share (EPS) | -1.15 |
Gross Margin | 76.95% |
Net Profit Margin | -42.87% |
Debt/Equity Ratio | 33.1% |
How did P75 perform over the long term?
See historical performance and comparison